Making the discoveries that defeat cancer

  • Home |
  • About Us  |
  • Research  |
  • Enterprise  |
  • Education  |
  • Jobs  |
  • Support Us  |
  • News  |
  • Contact Us
  • Home »
  • News »
  • Recent Featured Articles »
  • Featured Article Archive »
  • ICR Scientific Image Competition

News

  • Cancer Voices
  • Press Release Archive
  • PR Contacts
  • Recent Featured Articles
  • Research Highlights

ICR Scientific Image Competition

The Art of Science

The annual ICR Scientific Image Competition provides our scientists and students an opportunity to share the importance of their research through the visual means of images gathered during the research process.

Looking at the winning entries in this year's competition, it is hard not to feel that you are viewing artwork. 

 

David Birtill, PhD Student
Joint Department of Physics

ICR Scientific Image Winner David Birtill, Joint Department of Physics

This colourful image is a simulation of how a spherical tumour causes stresses in surrounding tissue. Images like this are formed by analysing the reflected pulses from an ultrasound scanner placed on the body, negating the need for ionising radiation such as x-rays.

"We can make fairly representative images of the relative stiffness in tissue, using a technique that does not image stiffness directly," explained David. Although the team’s simulations tend to be much sharper than this, and are more typically in monochrome, David found this image particularly appealing: “It shows artefacts as well as information, but it reminds me of a sunset reflecting off rippling water.”


Amir Faisal, Postdoctoral Training Fellow
CRUK Cancer Therapeutics Unit

ICR Scientific Image Winner Amir Faisal, CRUK Cancer Therapeutics Unit

When cells replicate, their genetic material is usually perfectly duplicated, and the cell then splits into two identical versions. In this image, a drug developed at the ICR has caused the cell to generate many more copies of its DNA (shown in blue), and to form multiple points of division (shown in red). As a result, the cell is unable to divide successfully into daughter cells, and it dies.

Amir, who is working on ways to use drugs that selectively target the proteins involved in cell division, finds the unique environment of the ICR to be ideal for scientific research. "I have the opportunity to work alongside chemists, clinicians and pharmacologists,” he said, “and to learn about their field as part of my own project.”


Marina Romanchikova, Postdoctoral Training Fellow
Joint Department of Physics

ICR Scientific Image Winner Marina Romanchikova, Joint Department of Physics

One way of preventing the growth of particularly persistent cancers is to inject a short-range radioactive substance directly into a tumour.

Marina’s image shows a simulation of radiation emitted during such treatment. The black oval is a cross-section through a patient’s skull, and the very bright area in the middle shows the irradiated tumour. 

Although the high-power radiation is constrained to the tumour, the radioactive substance also gives rise to weaker, long-range, ‘secondary’ radiation, which can be detected by a scanner. The glow around the patient shows that even small doses of radiation can lead to effects a long way from the tumour, as the secondary radiation interacts with molecules in the air, creating further sources of weak radiation.

Marina works on finding ways to tailor doses of radiation to patients, to protect healthy tissue. As Marina explains, “visualisation can help us to learn and memorise the effects of radiation as effectively as a textbook.”

Recent Featured Articles

  • Breast cancer patients with gene fault at increased risk of disease returning
  • Tackling cancer’s biggest challenge
  • Untangling the evolution of cancer
  • Combining imaging and gene analysis could transform breast cancer diagnosis
  • Single agent doxorubicin therapy for sarcoma
  • The ICR identity project
  • New drug type could boost chemotherapy
  • High quality of our clinical trials confirmed
  • Clinical trial tests new combination treatment for advanced prostate cancer
  • Funding injection into prostate cancer research
  • The ICR turns up the heat on tumour cells
  • The promise of immunotherapy - and bridging the funding gap
  • The Story of Abiraterone
  • Featured Article Archive

Featured Article Archive

  • Europe-wide cancer research competition winners
  • ICR drug discovery highlighted for patient impact
  • Prostate Cancer Progress
  • Vital Funding Continues for Cancer Research
  • New Type of Hormone Therapy Extends Prostate Cancer Patients’ Lives
  • Non-Surgical Cancer Treatment
  • Educating the Next Generation of Researchers
  • Novel BRAF Inhibitors
  • NCRI Cancer Conference 2011
  • Paul Workman features in BBC Radio 4 science special
  • Professor Philip Lawley
  • Professor Ian Judson on BBC Radio 4
  • Video: New protein stretches 2.5 times its length
  • ICR Scientific Image Competition
  • The Art of Structural Biology
  • canSAR Drug Discovery Database Launched
  • Myeloma IX Study
  • The Centre for Molecular Pathology
  • HPC: A Revolution in Cancer Research
  • BBC World highlights the future of personalised medicine in the UK
  • Testing New Radiotherapy Techniques for Breast Cancer
  • NICE issues draft guidance on abiraterone acetate
  • Buzz grows around PI3K drug
  • Global award for cancer drug success
  • Progress: Promising new targeted drugs revealed
  • The ICR features in BBC documentary Horizon
  • Abiraterone on the NHS


Last updated: 24 September 2012

The Royal Marsden - NHS foundation trust
  • Contacts  | 
  • Privacy  | 
  • Terms and Conditions  | 
  • Accessibility  | 
  • Feedback  | 
  • Cookies  | 
  • Status
  • ICR News RSS Feed
  • Find us on Facebook
  • Follow us on Twitter